GLA:D™ Canada Master’s Course

GLA:D Canada Masters Course

for GLA:D Clinicians

There are significant amounts of research on hip and knee OA every year which results in improved knowledge of the condition and response to treatments.

All clinicians who are treating patients with the GLA:D program are expected to be up to date in their knowledge of OA.

As such, we are offering a Masters Course to support GLA:D certified clinicians who took their course over 3 years ago to ensure that they have the latest information on the research to share with their patients.

This course is recommended for all clinicians who are currently treating patients with osteoarthritis. It is provided on a cost recovery basis at $70.

The course includes independent online video learning of 2 hours that will cover the new research as well as attendance at an 90 minute review session with a researcher and lead GLA:D clinician. This session will be a small group interactive format that focuses on answering clinicians’ questions and promoting information sharing.
 
Two 90-min remote review sessions are being offered to cover the time zones. You only need to attend 1 session. 
 
Wednesday, February 7, 2024
4:00-5:30 pm EDT (Toronto Time)
 
Cost: $70 (to cover expenses)
 

Register for a training course here:

https://cof.akaraisin.com/ui/MastersCourse/tickets

*Note this course is only for individuals who have previously been GLA:D certified, three or more years ago, to offer the program in Canada. If you have NOT been certified you need to register for the certification course first and ensure you have experience with the program prior to attending this Masters course. For anyone who registers inappropriately you will not be able to participate in the Masters course and we are unable to offer a refund. 

As this is held as a small group session there are limited spots available, which will be offered on a first-come-first-served basis.

Patients who have gone through the GLA:D™ Canada program are invited to share their feedback with this short form.


Subscribe to our Newsletter